Recent Finacing
Recent Raise
Eton Pharmaceuticals develops and plans to commercialize gelatin- and preservative-free sterile injectable candidates — including a synthetic 39‑amino‑acid ACTH analogue and a pentoxifylline Peyronie’s formulation — via FDA 505(b)(2) and DESI pathways.
Focus Areas
Total Raised
Funding round